February 3, 2016 — The nuclear medicine, proton therapy and brachytherapy markets represent less than 0.1 percent of ...
News | Oncology Diagnostics
January 29, 2016 — A biochemical compound developed as a radioactive tracer for cell proliferation shows increasing ...
January 29, 2016 
January 26, 2016 — University of Missouri researcher Silvia Jurisson and her interdisciplinary team recently received a ...
January 26, 2016 Sponsored Content
Videos | Contrast Media
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
February 27, 2023 
January 21, 2016 — Researchers at Thomas Jefferson University have found the method they developed to image the prostate ...
January 21, 2016 News | Prostate Cancer
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and ...
December 18, 2015 
News | Oncology Diagnostics
December 11, 2015 — Navidea Biopharmaceuticals Inc. announced that results from an investigator-initiated imaging study ...
December 11, 2015 Sponsored Content
Blog | Contrast Media Injectors
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
April 29, 2021 
November 3, 2015 — Australian immuno-oncology company Minomic International Ltd has struck an agreement to launch the ...
November 03, 2015 
October 19, 2015 — Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the ...
October 19, 2015 
October 2, 2015 — Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S ...
October 02, 2015 
News | PET Imaging
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...
September 23, 2015 
September 18, 2015 — A recently developed drug was significantly better at detecting recurring prostate cancer in early ...
September 18, 2015 
September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation ...
September 17, 2015 
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...
September 16, 2015 
News | Prostate Cancer
September 14, 2015 — ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's ...
September 14, 2015 
September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and ...
September 11, 2015 September 11, 2015 — Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of ...
September 11, 2015 
September 3, 2015 — Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business ...
September 03, 2015 
August 31, 2015 — NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 ...
August 31, 2015 
News | Prostate Cancer
August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish ...
August 21, 2015 
August 20, 2015 — The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a ...
August 20, 2015 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now